Intracranial stenosis – the best conservative treatment should be combined with a stent - NO

Czech version

Authors: prof. MUDr. Roman Herzig, Ph.D.; Feso; Fean
Authors‘ workplace: Neurologická klinika Komplexní cerebrovaskulární centrum LF UK a FN Hradec Králové
Published in: Cesk Slov Neurol N 2019; 82(4): 368
Category: Controversions

Sources

1. Derdeyn CP, Chimowitz MI, Lynn MJ et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet 2014; 383(9914): 333–341. doi: 10.1016/S0140-6736(13)62038-3.

2. Kwon SU, Cho YJ, Koo JS et al. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke 2005; 36(4): 782–786. doi: 10.1161/01.STR.0000157667.06542.b7.

3. Kwon SU, Hong KS, Kang DW et al. Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis. Stroke 2011; 42(10): 2883–2890. doi: 10.1161/STROKEAHA.110.609370.

4. Wang X, Lin WH, Zhao YD et al. The effectiveness of dual antiplatelet treatment in acute ischemic stroke patients with intracranial arterial stenosis: a subgroup analysis of CLAIR study. Int J Stroke 2013; 8(8): 663–668. doi: 10.1111/j.1747-4949.2012.00828.x.

5. Kernan WN, Ovbiagele B, Black HR et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45(7): 2160–2236. doi: 10.1161/STR.0000000000000024.

6. Powers WJ, Rabinstein AA, Ackerson T et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018; 49(3): e46–e110. doi: 10.1161/STR.0000000000000158.